Olga B. Solovieva
Research Subjects
Olga B. Solovieva has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Artem Z. Tsyganov
S.N. Fyodorov National Medical Research Center for Eye Microsurgery, Moscow, Russia
2 shared publications - Dmitry A. Dorofeev
Krasnov Research Institute of Eye Diseases
2 shared publications - Elena V. Kirilik
Chelyabinsk Public Clinical Hospital No. 2, Chelyabinsk, Russia
2 shared publications - Aleksandr A. Vitkov
Research Institute of Eye Diseases, Moscow, Russia
1 shared publication - Anastasiya S. Chemyakina
S.N. Fyodorov National Medical Research Center for Eye Microsurgery, Moscow, Russia
1 shared publication - Ilya V. Kokorin
St. Petersburg National Research University of Information Technology, Mechanics and Optics, Saint-Petersburg, Russia
1 shared publication
Latest Publications
- 30 September 2024
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 13 (3)
Reproducibility Of Retinal Nerve Fiber Layer And Macular Volume Measurements In Patients Receiving Retinal Protection Pharmacotherapy
Background — High-quality monitoring of the glaucoma plays an important role in the early diagnosis and treatment of glaucoma, for which structural optical coherence tomography (OCT) is used. Technology that increases the repeatability and reproducibility of OCT may differ in different devices, thereby yielding different results. Objective — To assess the effect of the frequency of retinal protection pharmacotherapy courses on quantitative data regarding the macular volume and the thickness of the retinal nerve fiber layer (RNFL) measured by two instruments, SPECTRALIS and OPTOPOL, and also to evaluate the agreement between the data collected by these devices. Material and Methods — We monitored 17 patients (34 eyes) diagnosed with primary open-angle glaucoma in the advanced stage from 2019 to 2023. Group 1 including 9 patients (18 eyes) received a course of retinal protection pharmacotherapy with Retinalamin® at an interval of 3 months, while Group 2 comprising 8 patients (16 eyes) received similar treatment at an interval of 6 months. All observed patients underwent structural OCT on REVO NX (OPTOPOL Technology) and SPECTRALIS devices at the onset of the study, as well as after 3 and 6 months. Results — The agreement between the two devices in measuring RNFL thickness was estimated by the Lin’s concordance correlation coefficient (LCCC): in manual mode, LCCCstart=0.69 (95% CI: 0.51-0.81); while in automatic mode, LCCCstart=0.73 (95% CI: 0.57-0.84). The agreement between the macular volume measurements was as follows: in manual mode, LCCCstart=0.21 (95% CI: 0.21-0.29); while in automatic mode, LCCCstart=0.21 (95% CI: 0.21-0.29). Conclusion — The agreement between the SPECTRALIS and OPTOPOL devices in terms of RNFL thickness should be considered substantial, while in terms of macular volume, it should be classified as fair. As measured in the manual mode, the RNFL thickness in both groups receiving Retinalamin increased, which can be interpreted as a favorable effect of retinal protection pharmacotherapy.
- 30 September 2024
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 13 (3)
Reproducibility Of Retinal Nerve Fiber Layer And Macular Volume Measurements In Patients Receiving Retinal Protection Pharmacotherapy
Background — High-quality monitoring of the glaucoma plays an important role in the early diagnosis and treatment of glaucoma, for which structural optical coherence tomography (OCT) is used. Technology that increases the repeatability and reproducibility of OCT may differ in different devices, thereby yielding different results. Objective — To assess the effect of the frequency of retinal protection pharmacotherapy courses on quantitative data regarding the macular volume and the thickness of the retinal nerve fiber layer (RNFL) measured by two instruments, SPECTRALIS and OPTOPOL, and also to evaluate the agreement between the data collected by these devices. Material and Methods — We monitored 17 patients (34 eyes) diagnosed with primary open-angle glaucoma in the advanced stage from 2019 to 2023. Group 1 including 9 patients (18 eyes) received a course of retinal protection pharmacotherapy with Retinalamin® at an interval of 3 months, while Group 2 comprising 8 patients (16 eyes) received similar treatment at an interval of 6 months. All observed patients underwent structural OCT on REVO NX (OPTOPOL Technology) and SPECTRALIS devices at the onset of the study, as well as after 3 and 6 months. Results — The agreement between the two devices in measuring RNFL thickness was estimated by the Lin’s concordance correlation coefficient (LCCC): in manual mode, LCCCstart=0.69 (95% CI: 0.51-0.81); while in automatic mode, LCCCstart=0.73 (95% CI: 0.57-0.84). The agreement between the macular volume measurements was as follows: in manual mode, LCCCstart=0.21 (95% CI: 0.21-0.29); while in automatic mode, LCCCstart=0.21 (95% CI: 0.21-0.29). Conclusion — The agreement between the SPECTRALIS and OPTOPOL devices in terms of RNFL thickness should be considered substantial, while in terms of macular volume, it should be classified as fair. As measured in the manual mode, the RNFL thickness in both groups receiving Retinalamin increased, which can be interpreted as a favorable effect of retinal protection pharmacotherapy.
- 20 March 2022
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 11 (1)
Perimetry Criteria For Assessing The Effectiveness Of Retinoprotective Therapy
Objective — To evaluate the effect of the frequency of retinoprotective therapy courses on perimetry parameters, to compare Octopus 900 perimeter with Octopus 600 perimeter, and to assess threshold perimetry results of G-dynamic versus 24-2 programs. Material and Methods — The study involved 17 patients (34 eyes) diagnosed with primary open-angle glaucoma of advanced stage. Group 1 included subjects receiving a course of Retinalamin every 3 months. Group 2 comprised patients undergoing Retinalamin therapeutics every 6 months. Results — At the onset of the study via G-dynamic and 24-2 programs, we did not observe any statistically significant differences between the groups in mean deviation of retinal photosensitivity (MD) and pattern standard deviation of mean retinal photosensitivity (PSD). However, the absolute values differed between groups and between programs. On average, the differences in MD and PSD values obtained in the photosensitivity study with G-dynamic vs. 24-2 programs were -0.36 dB (CI 95%: -4.27; 3.54) and 0.63 dB (CI 95%: 2.37; -1.11), respectively. Hence, studies performed via 24-2 and G-dynamic programs yielded comparable results (no statistically significant differences). However, they could not be identical due to different spatial arrangement of points in different programs. Conclusion — As a result of conducted treatment, retinal photosensitivity did not exhibit statistically significant changes; however, we observed positive dynamics in both groups in MD and PSD parameters of mean retinal photosensitivity. Different devices (Octopus 600 and Octopus 900 perimeters) and different programs (24-2, G-dynamic) yielded different outcomes due to their technical features and capabilities of reproducibility; however, these differences were not statistically significant.
- 20 March 2022
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 11 (1)
Perimetry Criteria For Assessing The Effectiveness Of Retinoprotective Therapy
Objective — To evaluate the effect of the frequency of retinoprotective therapy courses on perimetry parameters, to compare Octopus 900 perimeter with Octopus 600 perimeter, and to assess threshold perimetry results of G-dynamic versus 24-2 programs. Material and Methods — The study involved 17 patients (34 eyes) diagnosed with primary open-angle glaucoma of advanced stage. Group 1 included subjects receiving a course of Retinalamin every 3 months. Group 2 comprised patients undergoing Retinalamin therapeutics every 6 months. Results — At the onset of the study via G-dynamic and 24-2 programs, we did not observe any statistically significant differences between the groups in mean deviation of retinal photosensitivity (MD) and pattern standard deviation of mean retinal photosensitivity (PSD). However, the absolute values differed between groups and between programs. On average, the differences in MD and PSD values obtained in the photosensitivity study with G-dynamic vs. 24-2 programs were -0.36 dB (CI 95%: -4.27; 3.54) and 0.63 dB (CI 95%: 2.37; -1.11), respectively. Hence, studies performed via 24-2 and G-dynamic programs yielded comparable results (no statistically significant differences). However, they could not be identical due to different spatial arrangement of points in different programs. Conclusion — As a result of conducted treatment, retinal photosensitivity did not exhibit statistically significant changes; however, we observed positive dynamics in both groups in MD and PSD parameters of mean retinal photosensitivity. Different devices (Octopus 600 and Octopus 900 perimeters) and different programs (24-2, G-dynamic) yielded different outcomes due to their technical features and capabilities of reproducibility; however, these differences were not statistically significant.